Inhibition of p53 after acute myocardial infarction: Reduction of apoptosis is counteracted by disturbed scar formation and cardiac rupture

Journal of Molecular and Cellular Cardiology

Volumn 50, Issue 3, 2011, Pages 471-478

  Zhang, Ying ^a   Köhler, Katharina ^a   Xu, Jia ^a   Lu, Di ^a   Braun, Thomas ^b   Schlitt, Axel ^a   Buerke, Michael ^a   Müller Werdan, Ursula ^a   Werdan, Karl ^a   Ebelt, Henning ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

Author keywords

Apoptosis; MMP 2; Myocardial infarction; P53; Pifithrin alpha

Indexed keywords

COLLAGEN; GELATINASE A; PIFITHRIN ALPHA; PROTEIN P53;

ACUTE HEART INFARCTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL COUNT; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; ENZYME ACTIVITY; HEART INFARCTION SIZE; HEART RUPTURE; HOMOZYGOTE; IN VIVO STUDY; MALE; MOUSE; MYOCARDIAL DISEASE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; RAT; SCAR FORMATION; SURVIVAL RATE; SURVIVAL TIME; TRANSCRIPTION INITIATION;

ANIMALS; APOPTOSIS; BENZOTHIAZOLES; CELL PROLIFERATION; CELLS, CULTURED; COLLAGEN; HEART RUPTURE; HYDROGEN PEROXIDE; MALE; MATRIX METALLOPROTEINASE 2; MICE; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; RATS; TOLUENE; TRANSCRIPTIONAL ACTIVATION; TUMOR SUPPRESSOR PROTEIN P53;

MUS; RATTUS;

EID: 79551602745     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2010.11.006     Document Type: Article

References (35)

1. Sutton M.G., Sharpe N. Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. Circulation Jun. 27 2000, 101(25):2981-2988.
2. Reinecke H., Minami E., Zhu W.Z., Laflamme M.A. Cardiogenic differentiation and transdifferentiation of progenitor cells. Circ Res Nov. 7 2008, 103(10):1058-1071.
3. van Empel V.P., Bertrand A.T., Hofstra L., Crijns H.J., Doevendans P.A., De Windt L.J. Myocyte apoptosis in heart failure. Cardiovasc Res Jul. 1 2005, 67(1):21-29.
4. Wencker D., Chandra M., Nguyen K., Miao W., Garantziotis S., Factor S.M., et al. A mechanistic role for cardiac myocyte apoptosis in heart failure. J Clin Invest May 2003, 111(10):1497-1504.
5. Fridman J.S., Lowe S.W. Control of apoptosis by p53. Oncogene Dec. 8 2003, 22(56):9030-9040.
6. Crow M.T., Mani K., Nam Y.J., Kitsis R.N. The mitochondrial death pathway and cardiac myocyte apoptosis. Circ Res Nov. 12 2004, 95(10):957-970.
7. Long X., Boluyt M.O., Hipolito M.L., Lundberg M.S., Zheng J.S., O'Neill L., et al. p53 and the hypoxia-induced apoptosis of cultured neonatal rat cardiac myocytes. J Clin Invest Jun. 1 1997, 99(11):2635-2643.
8. Komarov P.G., Komarova E.A., Kondratov R.V., Christov-Tselkov K., Coon J.S., Chernov M.V., et al. A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science Sep. 10 1999, 285(5434):1733-1737.
9. Liu X., Chua C.C., Gao J., Chen Z., Landy C.L., Hamdy R., et al. Pifithrin-alpha protects against doxorubicin-induced apoptosis and acute cardiotoxicity in mice. Am J Physiol Heart Circ Physiol Mar. 2004, 286(3):H933-H939.
10. Liu P., Xu B., Cavalieri T.A., Hock C.E. Pifithrin-alpha attenuates p53-mediated apoptosis and improves cardiac function in response to myocardial ischemia/reperfusion in aged rats. Shock Dec. 2006, 26(6):608-614.
11. Muller-Werdan U., Klein D., Zander M., Werdan K., Hammer C. Beating neonatal rat cardiomyocytes as a model to study the role of xenoreactive natural antibodies in xenotransplantation. Transplantation Dec. 27 1994, 58(12):1403-1409.
12. Ebelt H., Hufnagel N., Neuhaus P., Neuhaus H., Gajawada P., Simm A., et al. Divergent siblings: E2F2 and E2F4 but not E2F1 and E2F3 induce DNA synthesis in cardiomyocytes without activation of apoptosis. Circ Res Mar. 18 2005, 96(5):509-517.
13. Soonpaa M.H., Field L.J. Survey of studies examining mammalian cardiomyocyte DNA synthesis. Circ Res Jul. 13 1998, 83(1):15-26.
14. Ebelt H., Jungblut M., Zhang Y., Kubin T., Kostin S., Technau A., et al. Cellular cardiomyoplasty: improvement of left ventricular function correlates with the release of cardioactive cytokines. Stem Cells Jan. 2007, 25(1):236-244.
15. Ebelt H., Braun T. Optimized, highly efficient transfer of foreign genes into newborn mouse hearts in vivo. Biochem Biophys Res Commun Oct. 31 2003, 310(4):1111-1116.
16. Ebelt H., Zhang Y., Kohler K., Xu J., Gajawada P., Boettger T., et al. Directed expression of dominant-negative p73 enables proliferation of cardiomyocytes in mice. J Mol Cell Cardiol Sep. 2008, 45(3):411-419.
17. Schafer K., Neuhaus P., Kruse J., Braun T. The homeobox gene Lbx1 specifies a subpopulation of cardiac neural crest necessary for normal heart development. Circ Res Jan. 10 2003, 92(1):73-80.
18. Matsumura S., Iwanaga S., Mochizuki S., Okamoto H., Ogawa S., Okada Y. Targeted deletion or pharmacological inhibition of MMP-2 prevents cardiac rupture after myocardial infarction in mice. J Clin Invest Mar. 2005, 115(3):599-609.
19. Nakajima H., Nakajima H.O., Tsai S.C., Field L.J. Expression of mutant p193 and p53 permits cardiomyocyte cell cycle reentry after myocardial infarction in transgenic mice. Circ Res Jun. 25 2004, 94(12):1606-1614.
20. Lindsey M.L. MMP induction and inhibition in myocardial infarction. Heart Fail Rev Jan. 2004, 9(1):7-19.
21. Menendez D., Inga A., Resnick M.A. The expanding universe of p53 targets. Nat Rev Cancer Oct. 2009, 9(10):724-737.
22. Oskarsson H.J., Coppey L., Weiss R.M., Li W.G. Antioxidants attenuate myocyte apoptosis in the remote non-infarcted myocardium following large myocardial infarction. Cardiovasc Res Feb. 2000, 45(3):679-687.
23. Zhao Z.Q., Velez D.A., Wang N.P., Hewan-Lowe K.O., Nakamura M., Guyton R.A., et al. Progressively developed myocardial apoptotic cell death during late phase of reperfusion. Apoptosis Aug. 2001, 6(4):279-290.
24. Matsusaka H., Ide T., Matsushima S., Ikeuchi M., Kubota T., Sunagawa K., et al. Targeted deletion of p53 prevents cardiac rupture after myocardial infarction in mice. Cardiovasc Res Jun. 1 2006, 70(3):457-465.
25. Lauten A., Majos E., Muhlich A., Wahlers T., Weider S., Fischer J.H., et al. Ischemia-reperfusion injury activates early extracellular matrix processing and expression of endostatin in the heart with differential effects of temperature. Basic Res Cardiol Sep. 2009, 104(5):559-569.
26. Zhao W., Fan G.C., Zhang Z.G., Bandyopadhyay A., Zhou X., Kranias E.G. Protection of peroxiredoxin II on oxidative stress-induced cardiomyocyte death and apoptosis. Basic Res Cardiol Jul. 2009, 104(4):377-389.
27. Jugdutt B.I. Ventricular remodeling after infarction and the extracellular collagen matrix: when is enough enough?. Circulation Sep. 16 2003, 108(11):1395-1403.
28. Whittaker P., Boughner D.R., Kloner R.A. Role of collagen in acute myocardial infarct expansion. Circulation Nov. 1991, 84(5):2123-2134.
29. Kleinbongard P., Heusch G., Schulz R. TNFalpha in atherosclerosis, myocardial ischemia/reperfusion and heart failure. Pharmacol Ther. Sep. 2010, 127(3):295-314.
30. Frantz S., Hu K., Adamek A., Wolf J., Sallam A., Maier S.K., et al. Transforming growth factor beta inhibition increases mortality and left ventricular dilatation after myocardial infarction. Basic Res Cardiol Sep. 2008, 103(5):485-492.
31. Jankowski M., Bissonauth V., Gao L., Gangal M., Wang D., Danalache B., et al. Anti-inflammatory effect of oxytocin in rat myocardial infarction. Basic Res Cardiol. Mar 2010, 10(2):205-218.
32. Conraads V.M., Vrints C.J., Rodrigus I.E., Hoymans V.Y., Van Craenenbroeck E.M., Bosmans J., et al. Depressed expression of MuRF1 and MAFbx in areas remote of recent myocardial infarction: a mechanism contributing to myocardial remodeling?. Basic Res Cardiol. Mar 2010, 105(2):219-226.
33. Ertl G., Frantz S. Healing after myocardial infarction. Cardiovasc Res Apr. 1 2005, 66(1):22-32.
34. Hayashidani S., Tsutsui H., Ikeuchi M., Shiomi T., Matsusaka H., Kubota T., et al. Targeted deletion of MMP-2 attenuates early LV rupture and late remodeling after experimental myocardial infarction. Am J Physiol Heart Circ Physiol Sep. 2003, 285(3):H1229-H1235.
35. Ducharme A., Frantz S., Aikawa M., Rabkin E., Lindsey M., Rohde L.E., et al. Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. J Clin Invest Jul. 2000, 106(1):55-62.